EFFECTS OF <i>Helicobacter pylori</i> ERADICATION ON MIGRAINE TREATMENT

SEYYEDMAJIDI M.1, BANIKARIM S.2, MOSHTAGHI M.3, IRANPOUR A.4, EMADI B.5, PEIVANDI B.6, ROSHANDEL G.7, MAGHSOODLOO A.8
1GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
2GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
3GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
4GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
5GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
6GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
7GRCGH, Golestan University of Medical Sciences, Gorgan, Iran.
8Department of Neurology, Golestan University of Medical Sciences, Gorgan, Iran.

Received : 14-11-2013     Accepted : 12-12-2013     Published : 30-12-2013
Volume : 1     Issue : 2       Pages : 31 - 33
World Res J Crit Care 1.2 (2013):31-33

Cite - MLA : SEYYEDMAJIDI M., et al "EFFECTS OF Helicobacter pylori ERADICATION ON MIGRAINE TREATMENT." World Research Journal of Critical Care 1.2 (2013):31-33.

Cite - APA : SEYYEDMAJIDI M., BANIKARIM S., MOSHTAGHI M., IRANPOUR A., EMADI B., PEIVANDI B., ROSHANDEL G., MAGHSOODLOO A. (2013). EFFECTS OF Helicobacter pylori ERADICATION ON MIGRAINE TREATMENT. World Research Journal of Critical Care , 1 (2), 31-33.

Cite - Chicago : SEYYEDMAJIDI M., BANIKARIM S., MOSHTAGHI M., IRANPOUR A., EMADI B., PEIVANDI B., ROSHANDEL G., and MAGHSOODLOO A. "EFFECTS OF Helicobacter pylori ERADICATION ON MIGRAINE TREATMENT." World Research Journal of Critical Care 1, no. 2 (2013):31-33.

Copyright : © 2013, SEYYEDMAJIDI M., et al, Published by Bioinfo Publications. This is an subscription based article distributed under the terms of the Creative Commons Attribution License, in which, you may not use the material for commercial purposes, you may not distribute the modified material.

Abstract

<i>Background:</i> Association between <i>Helicobacter Pylori</i> (HP) chronic infection and migraine has been studied but the results are controversial. In this study, we aimed to evaluate the effects of HP eradication during a 1-year follow-up in a population of patients affected by migraine without aura. <i>Methods:</i> 80 consecutive HP infected patients affected by migraine without aura were enrolled in the study. Patients in 2 groups were randomly assigned using 2 different regimens; Group A: migraine treatment and a 14-day triple therapy for HP infection and Group B: migraine treatment without HP eradication. The pain duration, headache severity and the frequency of clinical headache attacks were calculated upon enrollment in the study and at 6 months and 12 months after treatment. <i>Results:</i> In group A, HP infection was eradicated in 34 of 40 patients (85%). There were significant decrease in severity and frequency (but not in duration) of the migraine attacks at 6 months (p<0.001) and a significant decrease in intensity, frequency and duration of the migraine attacks at 12 months after HP treatment in eradicated patients (p<0.001). <i>Conclusions:</i> HP might be examined in migrainous patients and eradication treatment may be beneficial for the treatment of the disease.